All In MedTech

PMA device

Impella RP System

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

14

PMA pathway

Device trials

5

Naming "Impella RP"

MAUDE reports

1,716

Brand "Impella RP", since 2015

PubMed studies

105

Mentioning "Impella RP"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Impella RP System

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 6 of 14 decisions filed under this name.

3 more FDA decisions with a free account

Older decisions: P170011-S030, P170011-S029, P170011-S026, P170011-S025, P170011-S011, P170011-S003, P170011-S002, P170011

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "Impella RP", any status and sponsor, newest update first.

Open in Trial Radar
  • Tufts Medical CenterAcademic, hospital or other

    NCT04682483 · 20,000 participants (planned) · Start Dec 4, 2017 · Primary completion Dec 2027

    Device: Acute Mechanical Circulatory Support Devices · For: Cardiogenic Shock

    Sites: Weston, Florida; Chicago, Illinois; Indianapolis, Indiana · 22 sites in all

  • Abiomed Inc.Public (JNJ)

    NCT06637644 · 200 participants (planned) · Start May 29, 2024 · Primary completion Apr 1, 2026

    Device: Right-sided ventricular assist device · For: Right Ventricular (RV) Dysfunction

    Sites: Birmingham, Alabama; Tucson, Arizona; Little Rock, Arkansas · 31 sites in all

  • Abiomed Inc.Public (JNJ)

    NCT05820451 · 312 participants · Start Dec 15, 2022 · Primary completion Feb 22, 2024

    Device: Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution; Impella RP with Sodium Bicarbonate used as purge solution · For: Cardiogenic Shock; High Risk PCI

    Sites: Birmingham, Alabama; Tucson, Arizona; Little Rock, Arkansas · 20 sites in all

2 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Impella RP", and for the whole product code for context.

This brand

1,716 reports: 678 malfunction, 756 injury, 282 death

Whole product code PYX

2,234 reports: 850 malfunction, 956 injury, 428 death

Newest reports for this brand

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

18 more recall records with a free account

Published research

The most relevant PubMed records for "Impella RP"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code PYX.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.